RFK Jr. on Ozempic, Eli Lilly's next test, and Elon Musk gets on the bandwagon: Pharma news roundupByBruce GilPublishedDecember 13, 2024
A major food company is adding Ozempic-friendly badges to some productsByBruce GilUpdatedDecember 13, 2024
RFK Jr. says Ozempic and other weight-loss meds can't replace a healthy lifestyleByBruce GilPublishedDecember 12, 2024
The NLRB says Love is Blind contestants are employees. Here's what it means for NetflixByBruce GilPublishedDecember 12, 2024
Amazon and Walgreens are trying to make healthcare more accessible with technologyByBruce GilPublishedDecember 12, 2024
What can't weight-loss meds do? Eli Lilly is going to test obesity drugs as a treatment for addictionByBruce GilUpdatedDecember 11, 2024
Eli Lilly is partnering with Ro to make it easier than ever to get ZepboundByBruce GilPublishedDecember 11, 2024
Streaming accounted for 42% of TV viewing in November. These were the most-watched platforms, rankedByBruce GilPublishedDecember 10, 2024
A leaked video of UnitedHealth CEO defending denial practices sparks more online backlashByBruce GilPublishedDecember 9, 2024
Netflix, Disney, Hulu, and other streamers ranked by how similar they are to cableByBruce GilPublishedDecember 9, 2024
The '10 Americas': How geography, income, and ethnicity shape life expectancy in the U.S.ByBruce GilPublishedDecember 8, 2024
UnitedHealthcare and other insurers are pulling info about execs offline after a CEO was killedByBruce GilPublishedDecember 6, 2024
Ozempic cuts drinking, Zepbound beats Wegovy, and a blood test detects 50 cancers: Pharma news roundupByBruce GilPublishedDecember 6, 2024
Anthem takes back plan to limit anesthesia coverage after public backlashByBruce GilPublishedDecember 5, 2024
